↓ Skip to main content

Clinical Review: Navitoclax as a Pro-Apoptotic and Anti-Fibrotic Agent

Overview of attention for article published in Frontiers in Pharmacology, November 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
1 X user

Citations

dimensions_citation
86 Dimensions

Readers on

mendeley
125 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Clinical Review: Navitoclax as a Pro-Apoptotic and Anti-Fibrotic Agent
Published in
Frontiers in Pharmacology, November 2020
DOI 10.3389/fphar.2020.564108
Pubmed ID
Authors

Nur Najmi Mohamad Anuar, Nur Syahidah Nor Hisam, Sze Ling Liew, Azizah Ugusman

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 125 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 125 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 20 16%
Student > Ph. D. Student 14 11%
Student > Master 14 11%
Researcher 7 6%
Student > Doctoral Student 5 4%
Other 13 10%
Unknown 52 42%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 33 26%
Medicine and Dentistry 15 12%
Pharmacology, Toxicology and Pharmaceutical Science 6 5%
Agricultural and Biological Sciences 4 3%
Unspecified 3 2%
Other 7 6%
Unknown 57 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 January 2021.
All research outputs
#17,700,438
of 25,837,817 outputs
Outputs from Frontiers in Pharmacology
#7,822
of 20,002 outputs
Outputs of similar age
#332,933
of 529,079 outputs
Outputs of similar age from Frontiers in Pharmacology
#188
of 419 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 20,002 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 529,079 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 419 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.